Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study

C. Kodde (Berlin, Germany), F. Timmen (Bonn, Germany), S. Hohenstein (Leipzig, Germany), A. Bollmann (Leipzig, Germany), M. Bonsignore (Duisburg, Germany), R. Kuhlen (Berlin, Germany), I. Nachtigall (Berlin, Germany), S. Tasci (Siegburg, Germany)

Source: International Congress 2022 – COVID-19 acute respiratory distress syndrome and beyond

Session: COVID-19 acute respiratory distress syndrome and beyond
Session type: Oral Presentation
Number: 2312

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Kodde (Berlin, Germany), F. Timmen (Bonn, Germany), S. Hohenstein (Leipzig, Germany), A. Bollmann (Leipzig, Germany), M. Bonsignore (Duisburg, Germany), R. Kuhlen (Berlin, Germany), I. Nachtigall (Berlin, Germany), S. Tasci (Siegburg, Germany). Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study. 2312

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.